TOMASELLO, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 398
EU - Europa 301
AS - Asia 211
SA - Sud America 14
AF - Africa 8
Totale 932
Nazione #
US - Stati Uniti d'America 389
SG - Singapore 100
CN - Cina 95
IE - Irlanda 83
SE - Svezia 76
FI - Finlandia 37
IT - Italia 36
DE - Germania 22
NL - Olanda 14
BR - Brasile 13
CA - Canada 8
BE - Belgio 7
CI - Costa d'Avorio 6
RU - Federazione Russa 6
FR - Francia 5
GB - Regno Unito 5
TR - Turchia 5
LT - Lituania 4
CZ - Repubblica Ceca 3
IN - India 3
IR - Iran 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
DZ - Algeria 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
PH - Filippine 1
PL - Polonia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 932
Città #
Chandler 90
Dublin 83
Santa Clara 53
Singapore 53
New York 31
Ashburn 28
Shanghai 23
Ann Arbor 21
Boardman 18
Dearborn 17
Parma 16
Princeton 13
Nanjing 11
Helsinki 10
Beijing 9
Brussels 7
Abidjan 6
Bremen 6
Jinan 6
Izmir 5
Seattle 5
Toronto 5
Wilmington 4
Changsha 3
Frankfurt am Main 3
Guangzhou 3
Hebei 3
Hefei 3
London 3
Munich 3
Nanchang 3
Ottawa 3
Shenyang 3
Woodbridge 3
Atlanta 2
Fremont 2
Hangzhou 2
Marseille 2
Mestre 2
Modena 2
Moscow 2
Norwalk 2
Nuremberg 2
Pune 2
The Dalles 2
Tianjin 2
Zhengzhou 2
Almirante Tamandaré 1
Brooklyn 1
Campo Grande 1
Carlentini 1
Casalgrande 1
Chicago 1
Chongqing 1
Columbus 1
Council Bluffs 1
Córdoba 1
Des Moines 1
Dhaka 1
Diamantina 1
Erechim 1
Fayetteville 1
Fortaleza 1
Fuzhou 1
Haikou 1
Henderson 1
Husseïn Dey 1
Jiaxing 1
Kingston 1
Lanzhou 1
Leawood 1
Maceió 1
Manila 1
Messias 1
Monte Azul Paulista 1
Nazaré da Mata 1
Ningbo 1
Peruíbe 1
Phoenix 1
Redwood City 1
Rio Saliceto 1
Rockville 1
San Francisco 1
San Mateo 1
São Paulo 1
Taiyuan 1
Taizhou 1
Tashkent 1
Ust-Kamenogorsk 1
Varginha 1
Verona 1
Viamão 1
Vienna 1
Vientiane 1
Vladikavkaz 1
Warsaw 1
Wenzhou 1
Xian 1
Totale 630
Nome #
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer 113
Notch expression and bevacizumab efficacy in colorectal cancer patients 98
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 93
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer 91
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 88
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 85
Immunotherapy options in metastatic renal cell cancer: Where we are and where we are going 68
Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer 65
A pilot phase II study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer 57
Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon α-2a as first-line endocrine treatments in advanced breast cancer: Updated results of a phase II, prospective, randomised multicentre trial 50
Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: A case report 49
Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: Results of a phase II trial 48
Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimen 47
Totale 952
Categoria #
all - tutte 4.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.263


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 3 1 1 1 4 3 1 7 6 2 5 1
2021/202256 2 0 0 5 2 0 12 2 1 3 4 25
2022/2023283 34 42 19 17 17 32 4 16 92 0 9 1
2023/2024111 0 13 1 1 5 50 11 5 3 3 10 9
2024/2025290 12 14 23 30 44 48 1 13 58 30 17 0
Totale 952